Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group (British Journal of Cancer, (2018), 119, 5, (615-621), 10.1038/s41416-018-0212-9)

David S. Shulman, Kelly Klega, Alma Imamovic-Tuco, Andrea Clapp, Anwesha Nag, Aaron R. Thorner, Eliezer Van Allen, Gavin Ha, Stephen L. Lessnick, Richard Gorlick, Katherine A. Janeway, Patrick J. Leavey, Leo Mascarenhas, Wendy B. London, Kieuhoa T. Vo, Kimberly Stegmaier, David Hall, Mark D. Krailo, Donald A. Barkauskas, Steven G. DuBoisBrian D. Crompton

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

The authors have noticed that the final paragraph of the Results section contains errors in the number of patients involved. The correct number of patients is included in the text below. These errors do not affect the Figure referenced. In osteosarcoma, we focused on 8q gain as a specific biological feature of interest. Among the 41 patients with detectable ctDNA in the osteosarcoma cohort, 8q gain was detected in 73.2% (30/41). The 3-year EFS for patients with 8q gain (n = 30) in ctDNA was 60.0% (95% CI 40.5–75.0) compared to 80.8 (95% CI 42.4–94.9) in patients without 8q gain (n = 11) in ctDNA (p = 0.18; Fig. 3).

Original languageEnglish (US)
Pages (from-to)869
Number of pages1
JournalBritish journal of cancer
Volume120
Issue number8
DOIs
StatePublished - Apr 16 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group (British Journal of Cancer, (2018), 119, 5, (615-621), 10.1038/s41416-018-0212-9)'. Together they form a unique fingerprint.

Cite this